listed · IPO · BSE/NSE · listed 1 September 2026
Symbiotec Pharmalab Limited
Raised ₹1757.30 Cr at ₹988 per share.
+10.9%
listing-day move
Price band
₹938 – ₹988
Issue price
₹988
Issue size
₹1757.30 Cr
Listing-day close
₹1,095.95
Return since listing
+9.13%
Company research
Tijori FinanceSymbiotec Pharmalab Ltd., incorporated in 2002, is a pharmaceutical and biotechnology company manufacturing steroidal APIs, nutritional ingredients and specialty products. Its business spans organic chemistry, biotechnology and complex injectables, serving pharmaceutical, nutraceutical and wellness markets.
Financials — ₹ crore
| Period | Revenue | PAT | Debt |
|---|---|---|---|
| Mar 2024 | 716.25 Cr | 100.06 Cr | 247.21 Cr |
| Mar 2025 | 751.55 Cr | 96.79 Cr | 540.92 Cr |
| Mar 2026 | 869.15 Cr | 109.9 Cr | 387.91 Cr |
Revenue mix
Sale of APIs
96%
Sale of complex injectables
3.8%
CDMO services
0.1%
Others
0.0%
Peer comparison
Company Mkt cap Revenue P/E P/B
SYMBIOTEC 6,919 869 Cr 62.96 6.02
CONCORDBIO 15,153 1,054 Cr 55.03 7.51
DIVISLAB 2,45,426 10,560 Cr 83.91 14.64
COHANCE 17,605 2,268 Cr 165.73 4.5
LAURUSLABS 1,01,155 6,812 Cr 92.52 19.09
Exchange filings
Fields captured from NSE and BSEIssue information
- Symbol
- SYMBIOTEC
- Issue period
- 2026-08-24 to 2026-08-27
- Price range
- Rs.938 to Rs.988
- Red Herring Prospectus
- https://nsearchives.nseindia.com/corporate/SymbiotecPharmalabLimited_RHP.zip
Documents
Data sources: BSE , BSE , MONEYCONTROL , NSE , YAHOO , NSE . Data quality clean.